Literature DB >> 8643653

Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.

M Vitale1, S Sivori, D Pende, R Augugliaro, C Di Donato, A Amoroso, M Malnati, C Bottino, L Moretta, A Moretta.   

Abstract

Natural killer (NK) cells express clonally distributed receptors for different groups of HLA class I alleles. The Z27 monoclonal antibody described in this study recognizes a p70 receptor specific for HLA-B alleles belonging to the Bw4 supertypic specificity. Single amino acid substitutions in the peptide-binding groove of HLA-B2705 molecules influenced the recognition by some, but not all, p7O/Z27+ clones. This suggests the existence of a limited polymorphism within the p7O family of receptors. The pattern of reactivity of monoclonal antibody Z27 revealed that Bw4-specific receptors may be expressed alone or in combination with different (GL183 and/or EB6) p58 molecules. Analysis of NK clones coexpressing p58 and p7O receptors allowed us to demonstrate that the two molecules represent physically and functionally independent receptors. The expression of p7O molecules either alone or in combination with EB6 molecules provided the molecular basis for understanding the cytolytic pattern of two previously defined groups of "alloreactive" NK cell clones ("group 3" and "group 5").

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643653      PMCID: PMC39960          DOI: 10.1073/pnas.93.4.1453

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  An unexpected petition for pardon.

Authors:  K Kärre
Journal:  Curr Biol       Date:  1992-11       Impact factor: 10.834

2.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

Review 4.  Receptors for HLA class I molecules in human NK cells.

Authors:  C Bottino; M Vitale; D Pende; R Biassoni; A Moretta
Journal:  Semin Immunol       Date:  1995-04       Impact factor: 11.130

5.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).

Authors:  E Ciccone; D Pende; O Viale; A Than; C Di Donato; A M Orengo; R Biassoni; S Verdiani; A Amoroso; A Moretta
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

6.  Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding.

Authors:  K C Parker; W E Biddison; J E Coligan
Journal:  Biochemistry       Date:  1994-06-21       Impact factor: 3.162

Review 7.  Recognition of major histocompatibility complex class I antigens by natural killer cells.

Authors:  G Trinchieri
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

8.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

Authors:  A Moretta; G Tambussi; C Bottino; G Tripodi; A Merli; E Ciccone; G Pantaleo; L Moretta
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

9.  Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.

Authors:  A Moretta; M Vitale; S Sivori; C Bottino; L Morelli; R Augugliaro; M Barbaresi; D Pende; E Ciccone; M Lopez-Botet; L Moretta
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

10.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  19 in total

1.  Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation.

Authors:  William H Carr; David B Rosen; Hisashi Arase; Douglas F Nixon; Jakob Michaelsson; Lewis L Lanier
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 2.  The molecular basis of natural killer (NK) cell recognition and function.

Authors:  L Moretta; M C Mingari; D Pende; C Bottino; R Biassoni; A Moretta
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

Review 3.  HLA-C revisited. Ten years of change.

Authors:  C S Falk; D J Schendel
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions.

Authors:  A De Maria; A Ferraris; M Guastella; S Pilia; C Cantoni; L Polero; M C Mingari; D Bassetti; A S Fauci; L Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Contribution of functional KIR3DL1 to ankylosing spondylitis.

Authors:  Ivan V Zvyagin; Ilgar Z Mamedov; Olga V Britanova; Dmitriy B Staroverov; Evgeni L Nasonov; Anna G Bochkova; Anna V Chkalina; Alexei A Kotlobay; Dmitriy O Korostin; Denis V Rebrikov; Sergey Lukyanov; Yuri B Lebedev; Dmitriy M Chudakov
Journal:  Cell Mol Immunol       Date:  2010-09-06       Impact factor: 11.530

Review 6.  Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.

Authors:  A Moretta; D Pende; F Locatelli; L Moretta
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

Review 7.  Natural killer cell lines in tumor immunotherapy.

Authors:  Min Cheng; Jian Zhang; Wen Jiang; Yongyan Chen; Zhigang Tian
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 8.  NK cell-based immunotherapy for malignant diseases.

Authors:  Min Cheng; Yongyan Chen; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

9.  IL2rg Cytokines Enhance Umbilical Cord Blood CD34+ Cells Differentiation to T Cells.

Authors:  Zeynab Aliyari; Sara Soleimanirad; Manizheh Sayyah Melli; Hamid Tayefi Nasrabadi; Hojjatollah Nozad Charoudeh
Journal:  Adv Pharm Bull       Date:  2015-12-31

10.  Natural killer cell-mediated lysis of autologous cells modified by gene therapy.

Authors:  C Liberatore; M Capanni; N Albi; I Volpi; E Urbani; L Ruggeri; A Mencarelli; F Grignani; A Velardi
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.